Antitumour effect of OM-174 and Cyclophosphamide on murine B16 melanoma in different experimental conditions

International Immunopharmacology

Volumn 5, Issue 7-8, 2005, Pages 1205-1212

  D'Agostini, Cartesio ^a   Pica, Francesca ^a   Febbraro, Giuseppe ^a   Grelli, Sandro ^a   Chiavaroli, Carlo ^b   Garaci, Enrico ^a  

^a UNIVERSITY OF ROME TOR VERGATA   (Italy)

^b Vifor (International) Inc   (Switzerland)

Author keywords

B16 melanoma tumour; CTL response; Cyclophosphamide; Lymphocyte subsets; Natural killer activity; OM 174

Indexed keywords

CD4 ANTIGEN; CD8 ANTIGEN; CYCLOPHOSPHAMIDE; IMMUNOSTIMULATING AGENT; LIPID A DERIVATIVE; OM 174; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL MODEL; ANIMAL TISSUE; ANTINEOPLASTIC ACTIVITY; ARTICLE; CANCER INHIBITION; CANCER SURVIVAL; CELLULAR IMMUNITY; CONTROLLED STUDY; CYTOTOXIC T LYMPHOCYTE; DOSE RESPONSE; DRUG EFFECT; DRUG MECHANISM; DRUG MEGADOSE; IMMUNOLOGY; IMMUNOTHERAPY; LYMPHOCYTE SUBPOPULATION; MALE; MELANOMA; MELANOMA B16; MOUSE; NATURAL KILLER CELL; NONHUMAN; PRIORITY JOURNAL; SINGLE DRUG DOSE; SURVIVAL TIME;

ANIMALS; ANTINEOPLASTIC AGENTS; CD4-CD8 RATIO; CYCLOPHOSPHAMIDE; KILLER CELLS, NATURAL; LIPOPOLYSACCHARIDES; MALE; MELANOMA, EXPERIMENTAL; MICE; MICE, INBRED C57BL; T-LYMPHOCYTES, CYTOTOXIC;

EID: 19444386768     PISSN: 15675769     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.intimp.2005.02.013     Document Type: Article

References (16)

1. M. Imoto, S. Kusomoto, T. Shiba, E.T. Rietschel, C. Galanos, and O. Luderitz Chemical structure of E. coli lipid-A Tetrahedron Lett 26 1985 907 908
2. E. Ribi, K. Amano, J. Cantrell, S. Schwartzman, R. Parker, and K. Takayama Preparation and antitumor activity of non-toxic lipid A Cancer Immunol Immunother 12 1982 91 96
3. S. Ukei, J. Iida, T. Shiba, S. Kusumoto, and I. Azuma Adjuvant and antitumour activities of synthetic lipid A analogues Vaccine 4 1986 21 24
4. D. Reisser, A. Pance, and J.-F. Jeannin Mechanisms of the antitumoral effect of lipid A BioEssays 24 2002 284 289
5. R. Shimazu, S. Akashi, H. Ogata, Y. Nagai, K. Fukudome, and K. Miyake MD-2, a molecule that confers lipopolysaccharide responsiveness on Toll-like receptor 4 J Exp Med 189 1999 1777 1782
6. J.L. Swantek, M.H. Cobb, and T.D. Geppert Jun N-terminal kinase/stress-activated protein kinase (JNK/SAPK) is required for lipopolysaccharide stimulation of tumor necrosis factor alpha (TNF-α) translation: glucocorticoids inhibit TNF-α translation by blocking JNK/SAPK Mol Cell Biol 17 1997 6274 6282
7. N. Onier, S. Hilpert, L. Arnould, V. Saint-Giorgio, J.G. Davies, and J.F. Jeannin Cure of colon cancer metastasis in rats with the new lipid A OM 174. Apoptosis of tumor cells and immunization of rats Clin Exp Metastasis 17 4 1999 299 306
8. B. Pajak, V. Garze, J.G. Davies, J. Bauer, M. Mosier, and C. Chiavaroli The adjuvant OM-174 induces both the migration and maturation of murine dendritic cells in vivo Vaccine 21 9-10 2003 836 842
9. E. Garaci, A. Mastino, F. Pica, and C. Favalli Combination treatment using thymosin α1 and interferon after cyclophosphamide is able to cure Lewis lung carcinoma in mice Cancer Immunol Immunother 32 1990 154 160
10. A. Mastino, C. Favalli, S. Grelli, G. Rasi, F. Pica, and A.L. Goldstein Combination treatment with thymosin α1 potentiates the anti-tumor activity of interleukin 2 with cyclophosphamide in the treatment of the Lewis lung carcinoma in mice Int J Cancer 50 1992 493 499
11. E. Garaci, F. Pica, A. Mastino, A.T. Palamara, F. Belardelli, and C. Favalli Antitumor effect of thymosin α 1/interleukin 2 or thymosin α 1/interferon α,β following cyclophosphamide, in mice injected with highly metastatic Friend erythroleukemia cells J Immunother 13 1993 7 17
12. G. Rasi, G. Silecchia, P. Sinibaldi-Vallebona, E. Spaziani, P. Pierimarchi, and M. Sivilia Anti-tumor effect of combined treatment with thymosin alpha1 and interleukin-2 after 5-fluorouracil in liver metastases from colorectal cancer in rats Int J Cancer 57 1994 701 705
13. J.A. Wise, M.B. Mokyr, and S. Dray Effect of low-dose cyclophosphamide therapy on specific and nonspecific T cell-dependent immune response of spleen cells from mice bearing large MOPC-315 plasmocytomas Cancer Immunol Immunother 27 1988 191 197
14. R.J. North Cyclophosphamide-facilitated adoptive immunotherapy of established tumor depends on elimination of tumor induced suppressor cells J Exp Med 155 1982 1063 1074
15. C.B. Larmonier, L. Arnould, N. Larmonier, S. Baumann, M. Moutet, and V. Saint-Giorgio Kinetics of tumor cell apoptosis and immune cell activation during the regression of tumors induced by lipid A in a rat model of colon cancer Int J Mol Med 13 3 2004 355 361
16. C.H. Cho, B.K. Lee, S.M. Kwak, and J.D. Kim Monophosphoryl Lipid A (MPL) upregulates Major Histocompatibility Complex (MHC) class I expression by increasing interferon-γ (IFN-γ) Yonsei Med J 40 1 1999 20 25